Testing easier dosing to keep advanced colon cancer in check
NCT ID NCT05775900
Summary
This study tested whether giving two cancer drugs (cetuximab and capecitabine) less often could safely help control advanced colorectal cancer that had responded to initial treatment. It involved 24 adults with a specific genetic type of cancer that had spread. The main goals were to check the safety of the dosing schedule and how the drugs moved through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510655, China
Conditions
Explore the condition pages connected to this study.